The role of stavudine in the South African public sector antiretroviral programme: Should the perfect be the enemy of the good?
No abstract available.
Saved in:
Main Author: | Robin Wood (Author) |
---|---|
Format: | Book |
Published: |
AOSIS,
2006-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dolutegravir and the universal antiretroviral regimen: good may be the enemy of perfect
by: Reuben Granich, et al.
Published: (2018) -
Why should we still care about the stavudine dose?
by: Steve Innes, et al.
Published: (2011) -
Should we be initiating antiretroviral therapy earlier?
by: Robin Wood
Published: (2005) -
Is stavudine worth saving?
by: Tom Boyles
Published: (2012) -
A clinical assessment of antiretroviral-treated patients referred from the private sector to the South African government antiretroviral (ARV) programme: A retrospective analysis
by: Rianna Gounden
Published: (2011)